Bionexus Gene Lab appoints Matthew Barsing as Chairman

BioNexus Gene Lab (BGLC) announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation. As part of this restructuring, Chemrex’s board has been streamlined to two directors: Matthew Barsing, Chairman; Angeline Chong, Chief Financial Officer of BioNexus, Director. New officers are expected to be appointed in the coming months. Chemrex remains a wholly owned private subsidiary of BioNexus and operates under the oversight framework of the BioNexus Board of Directors and its committees.